Arrowhead Pharmaceuticals (Germany) Top Insiders

HDP1 Stock  EUR 21.10  0.45  2.18%   
Arrowhead Pharmaceuticals employs about 397 people. The company is managed by 10 executives with a total tenure of roughly 31 years, averaging almost 3.0 years of service per executive, having 39.7 employees per reported executive. Examination of Arrowhead Pharmaceuticals' management performance can provide insight into the company performance.
Christopher Anzalone  CEO
President CEO, Director
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Arrowhead Stock please use our How to Invest in Arrowhead Pharmaceuticals guide.

Arrowhead Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.1285) % which means that it has lost $0.1285 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4043) %, meaning that it generated substantial loss on money invested by shareholders. Arrowhead Pharmaceuticals' management efficiency ratios could be used to measure how well Arrowhead Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Arrowhead Pharmaceuticals Workforce Comparison

Arrowhead Pharmaceuticals is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 3,148. Arrowhead Pharmaceuticals retains roughly 397 in number of employees claiming about 13% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (0.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.57.

Arrowhead Pharmaceuticals Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Arrowhead Pharmaceuticals Price Series Summation is a cross summation of Arrowhead Pharmaceuticals price series and its benchmark/peer.

Arrowhead Pharmaceuticals Notable Stakeholders

An Arrowhead Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Arrowhead Pharmaceuticals often face trade-offs trying to please all of them. Arrowhead Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Arrowhead Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Christopher AnzalonePresident CEO, DirectorProfile
Tracie OliverChief OfficerProfile
Kenneth MyszkowskiChief OfficerProfile
Javier MDChief OfficerProfile
PharmD JDCOO CounselProfile
Howard LovyDirector CommunicationsProfile
Vincent CFAHead VPProfile
Mark DavisFounder CalandoProfile
MBA MDVP MedicineProfile
Mark SeefeldHead VPProfile

About Arrowhead Pharmaceuticals Management Performance

The success or failure of an entity such as Arrowhead Pharmaceuticals often depends on how effective the management is. Arrowhead Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Arrowhead management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Arrowhead management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. ARROWHEAD PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 116 people.

Arrowhead Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Arrowhead Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Arrowhead Pharmaceuticals within its industry.

Arrowhead Pharmaceuticals Manpower Efficiency

Return on Arrowhead Pharmaceuticals Manpower

Revenue Per Employee612.7K
Revenue Per Executive24.3M
Net Loss Per Employee443.5K
Net Loss Per Executive17.6M

Complementary Tools for Arrowhead Stock analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device